SCHEMBL4828919

SCHEMBL4828919

COc1cccc(CC(=O)Nc2ccc(N3CN=c4occc4=C3N)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MAPT P10636 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ CSF1R P07333 1/20 0.45
▸ PDGFRB P09619 1/20 0.45
▸ FLT4 P35916 1/20 0.45
▸ FLT3 P36888 1/20 0.45
▸ BRAF P15056 1/20 0.45
▸ USP2 O75604 1/20 0.44
▸ KCNQ2 O43526 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ PRKACA P17612 3/20 0.44
▸ ROCK1 Q13464 3/20 0.44
▸ KDM6B O15054 1/20 0.43
▸ KDM5A P29375 1/20 0.43
▸ KDM4D Q6B0I6 1/20 0.43
▸ KDM4C Q9H3R0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4828972 0.85 TP53 (0.51) LMNAMAPTKMT2AMEN1FLT3
SCHEMBL4827001 0.81 RAB9A (0.47) POLBMAPTKMT2AMEN1KDM4E
SCHEMBL4833594 0.79 PSEN1 (0.46) LMNAMAPTKMT2AMEN1CSF1R
SCHEMBL4833622 0.78 RAB9A (0.47) MAPTKMT2AMEN1PDGFRBFLT3
SCHEMBL4836002 0.78 MAPT (0.51) POLBLMNAMAPTKMT2AMEN1
SCHEMBL4833991 0.78 ALDH1A1 (0.49) LMNAGAAALDH1A1SMN1; SMN2
SCHEMBL4833522 0.77 TEK (0.49) POLBMAPTKMT2AMEN1CSF1R
SCHEMBL4832987 0.74 NPC1 (0.47) LMNAMAPTKMT2AMEN1USP2
SCHEMBL4826222 0.73 MCHR1 (0.46) LMNAMAPTCSF1RGAAKDM4E
SCHEMBL4833860 0.73 RAB9A (0.44) POLBMAPTKMT2AMEN1CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US claimed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US claimed
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US disclosed
US-7427623-B2 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof SMITHKLINE BEECHAM CORPORATION (US) 2008-09-23 — — US disclosed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US disclosed
EP-1425284-A2 FURO- AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-06-09 — — EP disclosed
WO-2003022852-A2 FURO-AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-03-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004142-A1 Chemical compounds TIE1, KDR, TEK POLB 928/4885LMNA 4230/4885MAPT 2499/4885
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF TIE1, TEK, KDR POLB 1327/4885LMNA 4131/4885MAPT 2424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback